Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
3,991.70
-116.85 (-2.84%)
BSENSE

Apr 02

BSE+NSE Vol: 8.24 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lupin
Aurobindo Pharma
Glenmark Pharma
Sun Pharma.Inds.
Torrent Pharma
Dr Reddy's Labs
Zydus Lifesci.
Alkem Lab
Divi's Lab.
Mankind Pharma
Cipla
Why is Torrent Pharmaceuticals Ltd. ?
1
High Management Efficiency with a high ROCE of 24.08%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.01 times
3
Poor long term growth as Net Sales has grown by an annual rate of 8.93% over the last 5 years
4
The company has declared Positive results for the last 9 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 22.56 times
  • ROCE(HY) Highest at 27.85%
  • PAT(Q) Highest at Rs 600.71 cr.
5
With ROCE of 30.4, it has a Very Expensive valuation with a 12.2 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 12.82%, its profits have risen by 24.6% ; the PEG ratio of the company is 2.4
6
High Institutional Holdings at 25.2%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Consistent Returns over the last 3 years
  • Along with generating 12.82% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Torrent Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Torrent Pharma for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Torrent Pharma
24.4%
0.58
22.08%
Sensex
-4.3%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.72%
EBIT Growth (5y)
13.39%
EBIT to Interest (avg)
9.32
Debt to EBITDA (avg)
1.40
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.92
Tax Ratio
24.47%
Dividend Payout Ratio
56.67%
Pledged Shares
0
Institutional Holding
25.28%
ROCE (avg)
23.21%
ROE (avg)
22.06%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
59
Industry P/E
31
Price to Book Value
15.99
EV to EBIT
40.87
EV to EBITDA
32.91
EV to Capital Employed
13.09
EV to Sales
10.76
PEG Ratio
2.45
Dividend Yield
0.73%
ROCE (Latest)
30.43%
ROE (Latest)
25.66%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 24.18 times

ROCE(HY)

Highest at 27.85%

NET SALES(Q)

Highest at Rs 3,303.00 cr

PBDIT(Q)

Highest at Rs 1,088.00 cr.

PBT LESS OI(Q)

Highest at Rs 837.00 cr.

PAT(Q)

Highest at Rs 642.80 cr.

DEBT-EQUITY RATIO(HY)

Lowest at 0.33 times

OPERATING PROFIT TO NET SALES(Q)

Highest at 32.94%

EPS(Q)

Highest at Rs 18.76

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.51 times

Loading Valuation Snapshot...
Here's what is working for Torrent Pharma
Operating Profit to Interest - Quarterly
Highest at 24.18 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 3,303.00 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,088.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 837.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 642.80 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 32.94%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Earnings per Share (EPS) - Quarterly
Highest at Rs 18.76
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Lowest at 0.33 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Torrent Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 5.51 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio